Kourosh Rezania, MD, is an expert in electromyography and neuromuscular diseases. He is particularly interested in the evaluation and treatment of a broad range of diseases that include peripheral neuropathies, metabolic myopathies, myasthenia gravis and amyotrophic lateral sclerosis (ALS).
Dr. Rezania is also an active researcher and teacher. Currently, he is conducting clinical trials on ALS.
The University of Chicago Medicine
IL
Fellowship
Mount Sinai Hospital
NY
Residency
New York Methodist Hospital
NY
Internship
Tehran University
Iran
MD
Intermuscular coherence from muscle pairs in the leg as a biomarker for amyotrophic lateral sclerosis.
Intermuscular coherence from muscle pairs in the leg as a biomarker for amyotrophic lateral sclerosis. Clin Neurophysiol. 2025 Nov; 179:2110986.
PMID: 40896928
Toward therapeutic trials in primary lateral sclerosis.
Toward therapeutic trials in primary lateral sclerosis. Amyotroph Lateral Scler Frontotemporal Degener. 2025 Nov; 26(7-8):623-630.
PMID: 40618376
Home-Based Tele-tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy.
Home-Based Tele-tDCS in Amyotrophic Lateral Sclerosis: Feasibility, Safety, and Preliminary Efficacy. Ann Clin Transl Neurol. 2025 May; 12(5):1022-1033.
PMID: 40125702
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
Pridopidine in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial. JAMA. 2025 Feb 17.
PMID: 40067755
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial.
Verdiperstat in Amyotrophic Lateral Sclerosis: Results From the Randomized HEALEY ALS Platform Trial. JAMA Neurol. 2025 04; 82(4):333-343.
PMID: 40067754
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial.
CNM-Au8 in Amyotrophic Lateral Sclerosis: The HEALEY ALS Platform Trial. JAMA. 2025 Feb 17.
PMID: 40067821
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial.
Efficacy and Safety of Zilucoplan in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial. JAMA Netw Open. 2025 02 03; 8(2):e2459058.
PMID: 39960672
Clinical Reasoning: A 65-Year-Old Woman With Isolated Macroglossia as the Initial Presentation of a Rare Disease.
Clinical Reasoning: A 65-Year-Old Woman With Isolated Macroglossia as the Initial Presentation of a Rare Disease. Neurology. 2024 Dec 24; 103(12):e210070.
PMID: 39561306
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study.
Intermuscular coherence as an early biomarker for amyotrophic lateral sclerosis: The protocol for a prospective, multicenter study. PLoS One. 2024; 19(5):e0303053.
PMID: 38776297
Added load increases the peak frequency of intermuscular coherence.
Added load increases the peak frequency of intermuscular coherence. J Electromyogr Kinesiol. 2024 Jun; 76:102881.
PMID: 38574588